BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17569228)

  • 1. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
    Pedersen K; Pandolfo M; Mavroudakis N
    Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
    Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
    Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists.
    Alshekhlee A; Basiri K; Miles JD; Ahmad SA; Katirji B
    Muscle Nerve; 2010 May; 41(5):723-7. PubMed ID: 20405504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
    Lai WW; Ubogu EE
    J Neurol Sci; 2007 Sep; 260(1-2):267-70. PubMed ID: 17521674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIg-induced acute polyneuroradiculitis in a patient with CIDP?
    Krasenbrink I; Kaps M; Blaes F
    Eur J Neurol; 2007 May; 14(5):e9. PubMed ID: 17437603
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy.
    Van den Bergh PY
    Acta Neurol Belg; 2001 Sep; 101(3):147-51. PubMed ID: 11817262
    [No Abstract]   [Full Text] [Related]  

  • 11. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
    Harbo T; Andersen H; Jakobsen J
    Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-responsive pudendal dysfunction in chronic inflammatory demyelinating polyneuropathy.
    Bussemaker L; Schelhaas HJ; Overeem S; Hopman WP; Zwarts MJ
    Neurology; 2007 Mar; 68(12):957-8. PubMed ID: 17372137
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy.
    Tamburin S; Zanette G
    Pain Med; 2009 Nov; 10(8):1476-80. PubMed ID: 19788714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy.
    Sivakumar K; Fife TD
    Neurology; 2005 Nov; 65(10):1673-4. PubMed ID: 16301508
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
    Mohamed AR; Rodriguez-Casero MV; Ryan MM
    Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.
    Richez C; Blanco P; Lagueny A; Schaeverbeke T; Dehais J
    Neurology; 2005 Apr; 64(8):1468-70. PubMed ID: 15851749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
    Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
    No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.